PHARMA DAIVE
ActiveSummary
PHARMA DAIVE has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €148,683 and a net result of €12,348. Equity is shrinking by about 3.6% per year across the filed financial years. Its solvency ranks better than 73% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-09
NBB filing
Annual accounts filed
financial year 2025 · micro format · 61 days late
2025
28-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
14-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 14 days late
2023
30-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 30 days late
2022
31-12
Financial
Highest result from 2018 to 2025net €50,417 ▲766%
Net result €50,417, the highest in the series.
07-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 7 days late
2021
31-12
Financial
Weakest financial yearnet €5,825 ▼68.9%
Net result drops to €5,825, the lowest in the series; recovery starts the following year.
28-11
NBB filing
Annual accounts filed
financial year 2020 · micro format · 120 days late
2019
31-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 31 days late
2018
31-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 31 days late
31-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 396 days late
2017
28-02
NBB filing
Annual accounts filed
financial year 2015 · full format · 212 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 35 annual accounts filed, the latest 10 are here; all 35 are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.